AKTS

Aktis Oncology, Inc. Health Care Pharmaceutical Preparations Russell 3000
$15.93Close $15.06 – $32.2352-week range Nov 12, 2026Next report

Highlights

Cautions

  • Distribution down-day volume 1.7× up-day volume over 50 sessions
  • Results soon Nov 12, 2026, in 11 days

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Trade setup

ATR% 6.3% $1.00 a day · 2×ATR $13.93
RS — vs the universe
Trend — trend template
Relative volume 0.6× vs 50-day average
Up/down volume 0.57 50 sessions
Implied move — no option chain · report Nov 12, 2026

Screen verdict

Not scorable — no annual report on file.

Last reported Aug 13, 2026
Results reaction Aug 13, 2026+3% vs market2 sessions after results

Filings

SEC EDGAR
FiledReportPeriod to Lag
Aug 13, 2026 Quarterly ↗ Jun 30, 2026 44d
May 11, 2026 Quarterly ↗ Mar 31, 2026 41d

Current reports

FiledDisclosed
Aug 13, 2026 Results ↗
May 11, 2026 Results ↗
Apr 16, 2026 Director or officer change · Regulation FD ↗
Mar 30, 2026 Results ↗
Jan 12, 2026 Charter or bylaws ↗